Daiwa Securities Group
PRQR icon

Daiwa Securities Group’s ProQR Therapeutics PRQR Stock Holding History

Daiwa Securities Group’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-208
Closed – – 1367
2022
Q3 		$0 Hold
208
– – ﹤0.01% 1378
2022
Q2 		$0 Sell
208
-18,669
-99% -$13.9K ﹤0.01% 1411
2022
Q1 		$17K Buy
18,877
+5,860
+45% +$19.6K ﹤0.01% 1115
2021
Q4 		$104K Buy
13,017
+2,352
+22% +$17.9K ﹤0.01% 1006
2021
Q3 		$89K Buy
+10,665
New +$69.7K ﹤0.01% 1001
2020
Q4 		– Sell
-246
Closed -$1K – 1293
2020
Q3 		$1K Hold
246
– – ﹤0.01% 1167
2020
Q2 		$32K Hold
246
– – ﹤0.01% 968
2020
Q1 		$1K Hold
246
– – ﹤0.01% 1194
2019
Q4 		$2K Hold
246
– – ﹤0.01% 1166
2019
Q3 		$1K Hold
246
– – ﹤0.01% 1158
2019
Q2 		$2K Hold
246
– – ﹤0.01% 1150
2019
Q1 		$3K Sell
246
-104
-30% -$1.55K ﹤0.01% 1109
2018
Q4 		$6K Buy
+350
New +$6.42K ﹤0.01% 1042

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Daiwa Securities Group's PRQR Position: Q4 2022 in Review

Daiwa Securities Group sold out of ProQR Therapeutics (PRQR) in Q4 2022, closing a stake of 208 shares.

Daiwa Securities Group first reported a position in PRQR in Q4 2018 and held it in 13 quarters. The position peaked at $104K in Q4 2021. 46 funds tracked by Wall St. Rank hold PRQR as of Q4 2022.

  • Daiwa Securities Group reported no remaining ProQR Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 208 ProQR Therapeutics shares in Q4 2022.
  • Daiwa Securities Group first reported a position in ProQR Therapeutics in Q4 2018 and held it in 13 quarters.
  • Daiwa Securities Group's ProQR Therapeutics position peaked at $104K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.